BridgeBio Pharma Inc (NASDAQ:BBIO)
| 26.34 Delayed Data As of 4:00pm ET |  -0.79 / -2.91%Today’s Change | 6.64 Today|||52-Week Range 36.36 | +245.67% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2017 | 2018 | -- | -- | |||
| Operating Activities | Net Income / Starting Line | -43.8M | -169.5M | -- | -- | |
| Depreciation | 260.0K | 245.0K | -- | -- | ||
| Total Other Cash Flow | 1.8M | 10.1M | -- | -- | ||
| Funds From Operations | -41.7M | -159.1M | -- | -- | ||
| Funds From/For Other Operating Expenses | -1.2M | -22.5M | -- | -- | ||
| Net Cash Flow - Operating Activities | -40.5M | -136.6M | -- | -- | ||
| Investing | Capital Expenditures | -464.0K | -2.2M | -- | -- | |
| Fixed Asset Disposal | 2.8M | 58.5M | -- | -- | ||
| Net Assets From Acquisitions | 0.00 | -44.2M | -- | -- | ||
| Other Investing - Uses | 0.00 | -2.9M | -- | -- | ||
| Net Cash Flow Investing | 2.4M | -6.8M | -- | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | -- | -- | -- |
| Long Term Borrowings | 4.1M | 57.4M | -- | -- | ||
| Long Term Debt Reduction | 0.00 | -1.1M | -- | -- | ||
| Net Proceeds Stock Sale | 107.2M | 431.0M | -- | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | -- | -- | -- | |
| Common Dividends | 0.00 | 0.00 | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | -- | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | -- | -- | -- | |
| Other Uses - Financing | 1.2M | 0.00 | -- | -- | ||
| Net Cash Flow - Financing | 110.1M | 487.3M | -- | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 72.0M | 343.9M | -- | -- | ||
